OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD
Mirjam de With, Leni van Doorn, Demi C. Maasland, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114232-114232
Open Access | Times Cited: 11
Mirjam de With, Leni van Doorn, Demi C. Maasland, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114232-114232
Open Access | Times Cited: 11
Showing 11 citing articles:
Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology
Mai Nagaoka, Yoshiyuki Sakai, Miki Nakajima, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116128-116128
Closed Access | Times Cited: 18
Mai Nagaoka, Yoshiyuki Sakai, Miki Nakajima, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116128-116128
Closed Access | Times Cited: 18
The effective combination therapies with irinotecan for colorectal cancer
Yun Chai, Jingli Liu, Shuo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Yun Chai, Jingli Liu, Shuo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
Anthi Maslarinou, Vangelis G. Manolopoulos, Georgia Ragia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Anthi Maslarinou, Vangelis G. Manolopoulos, Georgia Ragia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review
Yaping Liu, Jiapeng Li, Hao‐Jie Zhu
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 377-397
Closed Access | Times Cited: 3
Yaping Liu, Jiapeng Li, Hao‐Jie Zhu
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 377-397
Closed Access | Times Cited: 3
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
Mirjam de With, Leni van Doorn, Esmay Kloet, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 11, pp. 1589-1597
Open Access | Times Cited: 8
Mirjam de With, Leni van Doorn, Esmay Kloet, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 11, pp. 1589-1597
Open Access | Times Cited: 8
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
Yasmín Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2548-2548
Open Access | Times Cited: 4
Yasmín Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2548-2548
Open Access | Times Cited: 4
Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice
Dejun Kong, Zheng-lu Wang, Hao Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112955-112955
Closed Access | Times Cited: 1
Dejun Kong, Zheng-lu Wang, Hao Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112955-112955
Closed Access | Times Cited: 1
Association of Cytidine Deaminase Polymorphism with Capecitabine Effectiveness in Breast Cancer Patients
Ali Amal Aldeen Majeed, Ahmed Salih Sahib, Hasanian Shakir Mahmood, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 12, pp. 4219-4225
Open Access | Times Cited: 3
Ali Amal Aldeen Majeed, Ahmed Salih Sahib, Hasanian Shakir Mahmood, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 12, pp. 4219-4225
Open Access | Times Cited: 3
Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study
Chaichana Chantharakhit, Nantapa Sujaritvanichpong
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 1, pp. 73-77
Open Access | Times Cited: 2
Chaichana Chantharakhit, Nantapa Sujaritvanichpong
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 1, pp. 73-77
Open Access | Times Cited: 2
Therapy-related hand-foot syndrome: a review
Bilha Baby, Nevin Sam, M P Narmadha, et al.
Journal of Chemotherapy (2024), pp. 1-12
Closed Access
Bilha Baby, Nevin Sam, M P Narmadha, et al.
Journal of Chemotherapy (2024), pp. 1-12
Closed Access
Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial
Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh, et al.
Deleted Journal (2024) Vol. 23, Iss. 1
Open Access
Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh, et al.
Deleted Journal (2024) Vol. 23, Iss. 1
Open Access
